Health and Economic Benefits of Complying With the World Health Organization Air Quality Guidelines for Particulate Matter in Nine Major Latin American Cities.


Journal

International journal of public health
ISSN: 1661-8564
Titre abrégé: Int J Public Health
Pays: Switzerland
ID NLM: 101304551

Informations de publication

Date de publication:
2024
Historique:
received: 29 11 2023
accepted: 08 05 2024
medline: 17 6 2024
pubmed: 17 6 2024
entrez: 17 6 2024
Statut: epublish

Résumé

This study aims to estimate the short-term preventable mortality and associated economic costs of complying with the World Health Organization (WHO) air quality guidelines (AQGs) limit values for PM We estimated city-specific PM-mortality associations using time-series regression models and calculated the attributable mortality fraction. Next, we used the value of statistical life to calculate the economic benefits of complying with the WHO AQGs limit values. In most cities, PM concentrations exceeded the WHO AQGs limit values more than 90% of the days. PM Our findings suggest that there is an urgent need for policymakers to develop interventions to achieve sustainable air quality improvements in Latin America. Complying with the WHO AQGs limit values for PM

Identifiants

pubmed: 38882560
doi: 10.3389/ijph.2024.1606909
pii: 1606909
pmc: PMC11176932
doi:

Substances chimiques

Particulate Matter 0
Air Pollutants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1606909

Informations de copyright

Copyright © 2024 Madaniyazi, Alpízar, Cifuentes, Riojas-Rodríguez, Hurtado Díaz, de Sousa Zanotti Stagliorio Coelho, Abrutzky, Osorio, Carrasco Escobar, Valdés Ortega, Colistro, Roye and Tobías.

Déclaration de conflit d'intérêts

The authors declare that they do not have any conflicts of interest.

Auteurs

Lina Madaniyazi (L)

School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.

Jefferson Alpízar (J)

School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.

Luis Abdón Cifuentes (LA)

Departamento de Ingeniería, Pontificia Universidad Católica de Chile, Santiago, Chile.

Horacio Riojas-Rodríguez (H)

National Institute of Public Health (Mexico), Cuernavaca, Mexico.

Magali Hurtado Díaz (M)

National Institute of Public Health (Mexico), Cuernavaca, Mexico.

Micheline de Sousa Zanotti Stagliorio Coelho (M)

Urban Health Laboratory University of São Paulo, Faculty of Medicine, São Paulo, Rio Grande do Sul, Brazil.

Rosana Abrutzky (R)

Universidad de Buenos Aires, Facultad de Ciencias Sociales, Instituto de Investigaciones Gino Germani, Buenos Aires, Argentina.

Samuel Osorio (S)

National Institute of Public Health (Mexico), Cuernavaca, Mexico.

Gabriel Carrasco Escobar (G)

Health Innovation Laboratory, Institute of Tropical Medicine "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.

Nicolás Valdés Ortega (N)

Departamento de Ingeniería, Pontificia Universidad Católica de Chile, Santiago, Chile.

Valentina Colistro (V)

Department of Quantitative Methods, School of Medicine, University of the Republic, Montevideo, Uruguay.

Dominic Roye (D)

CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Aurelio Tobías (A)

Institute of Environmental Assessment and Water Research, Spanish National Research Council (CSIC), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH